HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Google Scholar Articles by Weir, N U PubMed PubMed Citation Articles by Weir, N U

Calgary, Canada

Attending Neurologist, Calgary Stroke Program, Department of Clinical Neurosciences, Foothills Medical Centre, Room 1079, 1403-29th Street NW, Calgary, Alberta T2N 2T9, Canada; nicweir@hotmail.com

The first 150 words of the full text of this article appear below.

Time is brain, as all good stroke physicians know. Quite how, therefore, a fence-sitting, slow-coach UK-trained neurologist like me has ended up as a stroke neurologist in Calgary, one of the cradles of rapid stroke medicine, remains something of a mystery (and never more so than when my pager goes off at two o’clock in the morning for an "acute run"). And yet, here I am and thriving on it. Back home, the UK is just starting to take acute stroke seriously, and the recent publication of its National Stroke Strategy, emphasising the importance of thrombolysis for acute ischaemic stroke and speedy secondary prevention for high-risk transient ischaemic attack (TIA) patients, is a welcome step forward. Calgary’s claim to fame, however, is that it has "been there" and "done that" for quite some time now.

The publication of the now classic NINDS paper showing that intravenous tissue plaminogen activator (tPA) . . . [Full text of this article]